Today: 5 June 2026
Browse Category

NASDAQ:ABBV 30 January 2026 - 31 January 2026

AbbVie stock (ABBV) firms up into earnings week as markets turn cautious

AbbVie stock (ABBV) firms up into earnings week as markets turn cautious

AbbVie shares rose 1.17% to $223.01 Friday, outperforming a broader market dip after Donald Trump nominated Kevin Warsh to lead the Federal Reserve. Trading volume in AbbVie topped its 50-day average ahead of next week’s earnings report. The stock remains about 9% below its 52-week high. AbbVie will release results and hold its earnings call early Wednesday.
31 January 2026
···
AbbVie stock rises as ABBV heads into Feb. 4 earnings; Botox price talks in focus

AbbVie stock rises as ABBV heads into Feb. 4 earnings; Botox price talks in focus

AbbVie shares rose about 1% Friday, closing near $222.73 ahead of its Feb. 4 earnings report and first 2026 guidance. Investors are watching Botox pricing risks after Medicare listed it for price negotiations, and new aesthetics data from Paris. The stock dropped 2.35% Wednesday, ending a five-day rally. Goldman Sachs kept a neutral rating with a $223 target.
30 January 2026
···

Stock Market Today

  • Deutsche Bank Sees Robinhood's Prediction Market Move Boosting Stock
    June 5, 2026, 12:04 PM EDT. Robinhood's recent entry into prediction markets through its joint venture platform Rothera is expected to improve its stock performance, according to Deutsche Bank. The stock has fallen over 40% from its 52-week high. Deutsche Bank maintained a buy rating and raised the price target to $98, suggesting an 11% increase. Rothera will handle select event contracts, including those linked to the 2026 World Cup and professional baseball, offering lower transaction fees capped at 1 cent per contract compared to competitors. Analyst Brian Bedell highlighted the strategic timing to boost engagement, noting substantial trading volume with over 16 billion contracts traded year-to-date in 2026. Robinhood will continue to list contracts from other platforms, but the new lower-fee structure and exchange could drive greater user participation and revenue growth.

Latest articles

BioCardia Jumps After FDA Feedback Seen Positive for CardiAMP Approval

BioCardia Jumps After FDA Feedback Seen Positive for CardiAMP Approval

5 June 2026
BioCardia shares soared 52% to $1.40 after FDA meeting minutes confirmed its CardiAMP HF II trial may support a PMA for heart-failure cell therapy, bucking a weak biotech sector; the move highlights investor focus on regulatory progress, though risks remain with cash needs and Nasdaq compliance.
SOXL Up 433% This Year But Stalls as Chip Stocks Drop

SOXL Up 433% This Year But Stalls as Chip Stocks Drop

5 June 2026
SOXL plunged 14.6% to $224.36 as chip stocks tumbled after strong U.S. jobs data fueled rate-hike fears, erasing part of its 433% year-to-date rally and spotlighting the risks of triple-leveraged ETFs, which can magnify losses as quickly as gains.
Costco Gas Sees Jump in Sales, but the $65 Membership Still Applies

Costco Gas Sees Jump in Sales, but the $65 Membership Still Applies

5 June 2026
Costco’s May sales surged 14.5% as booming gasoline business and higher pump prices fueled a $662 million sales boost, driving net sales to $24.01 billion and pushing shares up $16.40 to $988.75 Friday, with executives citing record fuel demand and price-conscious shoppers flocking to Costco’s cheaper pumps.
Dow slips in New York after jobs data boosts rate-hike talk

Dow slips in New York after jobs data boosts rate-hike talk

5 June 2026
Dow slips 0.21% as stronger-than-expected U.S. jobs report sends Treasury yields higher, raising chances of a Fed rate hike before year-end to 98% and pressuring stocks—tech and chip shares tumble, while defensive sectors gain, with Cisco and IBM dragging the Dow and the S&P 500 on track for its first weekly loss since April.
AI-driven stocks stall on Wall Street after jobs report shakes chip sector

AI-driven stocks stall on Wall Street after jobs report shakes chip sector

5 June 2026
Chip stocks plunged Friday, with Broadcom down 4.5% and Nvidia 3.7%, after a stronger-than-expected May jobs report fueled fears the Fed may delay or reverse rate cuts, slamming AI-linked shares that powered this year’s rally; Broadcom’s revenue and AI chip forecast missed Wall Street estimates, triggering a 4.7% drop in the semiconductor ETF as investors demanded perfection.
Go toTop